Riskpilot← Back to searchSign inGet full accessKarOlin Medical AB
ABActiveOrg 5593319816Råggatan 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 20210 employees
Revenue 2024
SEK 403K
+295% vs 2023
EBITDA margin
22.1%
+224% vs 2023
Equity ratio
47.0%
Financial strength
Net profit 2024
SEK 85K
+218% vs 2023
| Revenue | SEK 403K | +295% |
| EBITDA | SEK 89K | +224% |
| Net profit | SEK 85K | +218% |
| Total assets | SEK 296K | +179% |
| Equity | SEK 139K | +155% |
| Employees | 0 | — |
Legal name
KarOlin Medical AB
Org number
5593319816
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25 augusti 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av Malmros, Ann Karina Olin, Anders Ingvar Zander Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företag som sysslar med Life Scienceforskning framförallt inom cellbiologi och apoptos.
Address
Råggatan 1
Email
karina.malmros@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 181 | 102 | 403 |
| Staff expenses | — | — | — |
| EBITDA | 128 | −72 | 89 |
| Depreciation & amort. | — | — | −0 |
| EBIT | 128 | −72 | 89 |
| Net financials | — | — | — |
| Profit before tax | 96 | −72 | 89 |
| Tax | −20 | — | −4 |
| Net profit | 76 | −72 | 85 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 211 | 106 | 296 |
| Equity | 126 | 54 | 139 |
| Long-term debt | — | — | 0 |
| Short-term debt | 53 | 20 | 125 |
| Total debt | 53 | 20 | 125 |
EBITDA margin
22.1%
This company
15.8%
Market median
+40% vs market
20222024
Equity ratio
47.0%
This company
38.2%
Market median
+23% vs market
20222024
Return on equity
61.2%
This company
18.4%
Market median
+233% vs market
20222024
Net profit margin
21.1%
This company
8.1%
Market median
+160% vs market
20222024
Asset turnover
1.36×
This company
1.12×
Market median
+21% vs market
20222024
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AK Chief Executive Officer | Chief Executive Officer | 2025 |
AI Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KarOlin Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann Karina Malmros | Chief Executive Officer | 0 companies |
| Anders Ingvar Zander Olin | Deputy Chief Executive Officer | 0 companies |
| Berit Inga Barbro Olin | Deputy Board Member | 0 companies |
| Anders Bernt Ståhl | Board of Directors | 0 companies |
| Sofie Isabella Sköld | Board of Directors | 0 companies |
| Johan Fredrik Örtendahl | Board of Directors | 0 companies |